drugset / Trial / NCT02901249
Cost- Effectiveness and Quality of Life Assessment in Major Depression Disorder
NaSequentialOpen-labelTreatment
Summary
To evaluate the effectiveness of one algorithm for Major Depression Disorder (MDD) using medications available in the Brazilian Public Healthcare System (SUS), and assessment of the quality of life of these patients. A randomized pragmatic trial was conducted. An algorithm was developed for the treatment of episodes of unipolar depression episodes.
Timeline
- Start
- 2010-05
- Primary completion
- 2014-11
- Completion
- 2015-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Lithium | Unknown | 900 mg | — |
| Subject | Lithium | Unknown | 1500 mg | — |
| Subject | Nortriptyline | Small molecule | 100 mg | — |
| Subject | Sertraline | Small molecule | 50 mg | — |
| Subject | Sertraline | Small molecule | 200 mg | — |